Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Jardiance (empagliflozin) and Victoza (liraglutide) are both medications used to manage Type 2 diabetes, but they work in different ways and have different forms. Jardiance is a sodium-glucose co-transporter 2 (SGLT2) inhibitor taken as a pill once a day, while Victoza is a Glucagon-like peptide-1 (GLP-1) agonist that you inject once a day. Jardiance helps lower blood sugar by making your body get rid of extra sugar through urine and also helps with heart failure and chronic kidney disease. Victoza, on the other hand, helps your body release more insulin, stops it from releasing too much sugar, and slows down digestion. Jardiance can cause urinary tract infections and yeast infections, while Victoza can cause nausea, vomiting, and diarrhea. Jardiance is currently only available as a brand-name medication, with generics expected in 2025, whereas Victoza does not have a generic form. Both medications can help with weight loss, but neither is specifically approved for this purpose.
Victoza (liraglutide) is a medication that's injected once a day. It helps lower blood sugar levels in people 10 years and older with Type 2 diabetes when used with a nutritious diet and regular exercise. It can also help lower the risk of heart-related problems in adults with Type 2 diabetes and heart disease. Victoza (liraglutide) belongs to the drug class called GLP-1 agonists. The medication comes as single-dose prefilled pens and is injected under the skin. It can cause side effects like nausea, vomiting, diarrhea, and constipation. Victoza (liraglutide) is available as both a brand-name and generic medication.
Indications of Jardiance vs. Victoza
Indications for
•Type 2 diabetes (in addition to diet and exercise) in people age 10 years and older
•Lowering the risk of death due to heart problems in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization and death due to heart problems in adults with heart failure
•Lowering the risk of worsening kidney problems, hospitalization, and death due to heart problems in adults with chronic kidney disease (CKD)
Indications for
•Type 2 diabetes in people age 10 and older, together with a balanced diet and exercise
•Lowering the risk of serious heart-related problems in adults with Type 2 diabetes and heart disease